Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a rare autoimmune entity in psychiatry literature that occurs when antibodies attack NMDA-type glutamate receptors in the brain. Principle clinical features include a neurological domain such as seizure, orofacial dyskinesia, dystonia, and choreic-like movements of extremities. Also the psychiatric manifestations of this form of encephalitis may vary from psychotic-like symptoms to mood symptoms like depression or mania. Herein we report on five female child cases diagnosed with anti-NMDAR encephalitis, presented with both neurological and psychiatric clinical picture, and highlight the trajectory of disorder from a psychiatric perspective.
We evaluated clinical parameters distinguishing cognitive disengagement syndrome (CDS) and childhood absence epilepsy (CAE). 40 children with CDS, 27 with CAE, and 41 controls aged 7-12 were compared regarding sleep problems, CDS, and ADHD symptoms. CDS-sluggishness symptoms, but not CDS-daydreaming symptoms, were significantly higher in CDS group than CAE group. CDS scale provided a weak discrimination value between CDS and CAE. Sleep problems and ADHD symptoms were similar between the two clinical entities. These findings highlight that CDS and CAE might have overlapping symptoms. 'Daydreaming' symptoms but not 'sluggishness' symptoms seem to be main overlapping manifestations between CDS and CAE.
Background: Evidence regarding the association between early childhood exposure to general anesthesia (GA) and later attention-deficit/hyperactivity disorder (ADHD) remains inconsistent. Moreover, the relationship between GA exposure and oppositional defiant disorder (ODD) comorbidity has not been sufficiently investigated. This study examined whether GA exposure is associated with dimensional ADHD and ODD symptom severity and categorical ODD comorbidity in a medication-naïve clinical sample.Methods: This cross-sectional study included 92 medication-naïve children aged 7–12 years diagnosed with ADHD (n=63) or ADHD+ODD (n=29). Children with additional psychiatric comorbidities were excluded. GA exposure history (presence, number, and age at exposure) was obtained retrospectively from parents. Dimensional symptoms were assessed using the DSM-IV–based Disruptive Behavior Disorders Rating Scale. Results: GA exposure was not significantly associated with ADHD+ODD comorbidity (χ²=2.668, p=0.102) or ADHD presentation type (χ²=3.029, p=0.082). After adjustment for age, sex and trauma history, GA-exposed children had higher inattention scores than non-exposed children (F(1,89)=9.278, p=0.003, partial η²=0.094). Inattention scores also significantly differed by number of GA exposures and age at first exposure. However, GA exposure characteristics were not significantly associated with hyperactivity–impulsivity, ODD, or conduct disorder scores.Conclusions: GA exposure was not associated with ODD symptom severity, categorical ODD comorbidity, ADHD presentation type, or broader disruptive behavior symptom dimensions. Although adjusted analyses suggested higher inattentive symptom severity among GA-exposed children, this finding should be interpreted cautiously. Larger longitudinal studies are needed to clarify whether GA exposure has an independent role in ADHD symptom expression or ODD comorbidity.